Explore News
-
GLP-1 Drugs Show Promise Against Arthritis: 70% Lower Joint Inflammation
New research shows GLP-1 receptors in arthritic joints, suggesting drugs like Wegovy may directly reduce…
-
78% of Users Report Reduced Food Cravings on GLP-1s
New research illuminates how drugs like Ozempic and Mounjaro suppress ‘food noise,’ transforming the way…
-
New Oral Delivery Method Boosts GLP-1 Drug Efficacy by 80%
A novel delivery system from Duke University allows patients to take GLP-1 medications orally with…
-
Medicare Bets $15B on Lower Drug Prices by 2027
A new ‘most favored nation’ pricing policy aims to slash costs for blockbuster weight-loss and…
-
GLP-1 Drugs Reshape Obesity Care, New Guidelines Urge Dietitian-Led Approach
New international consensus emphasizes multidisciplinary care as GLP-1 medications surge in use, highlighting the critic
-
Obesity Drugs Cut Asthma Attacks by 26%, Study Reveals
New research shows GLP-1 drugs are associated with significantly fewer asthma flare-ups and reduced reliance…
-
GLP-1 Drugs Surge as Bariatric Surgeries Decline: What It Means
A nationwide decline in bariatric procedures coincides with the rapid adoption of GLP-1 medications, reshaping…
-
New GLP-1 Drug Shows Promise for Weight Loss
A new weight loss drug has shown promising results in a phase 3 clinical trial
-
Why GLP-1 Weight-Loss Drugs May Be Safe During Pregnancy
New research suggests Ozempic and similar medications do not pose a significant threat
-
Hair Treatment Market Surges on GLP-1 Side Effects
Hair loss from GLP-1 weight loss drugs creates new market
